<DOC>
	<DOCNO>NCT00511524</DOCNO>
	<brief_summary>GW842166X develop treatment management inflammatory pain . GW842166X CB2 receptor agonist mechanism fully understood , although think anti-inflammatory action drug require cross inot brain blood . This study aim look drug cross brain give orally use image technique call positron emission tomography .</brief_summary>
	<brief_title>An Imaging Study Investigate Distribution GW842166X Brain .</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<criteria>Male age 50 80yrs inclusive screen visit . subject negative HIV hepatitis B C test result within 3 month study start . A negative Allens test arm use arterial cannulation . Any contraindication MRI scan . History presence hepatic renal disease . Previous involvement PET radiological investigation . Family history cancer . History claustrophobia Presence cardiac pacemaker electronic device ferromagnetic metal</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>CB2 ,</keyword>
	<keyword>PET</keyword>
	<keyword>brain ,</keyword>
	<keyword>inflammation ,</keyword>
	<keyword>analgesia ,</keyword>
</DOC>